focus -WSS

focus

author：knowledge 2025-10-01 12:11:29 - browse：194

Stock exchange — Drew Angerer/Getty Images

Viking Therapeutics said Tuesday that its closely watched oral obesity drug had succeeded in an early-stage trial and that it planned to advance the medicine into the next phase of development.

The top-line results released Tuesday were only from a Phase 1 study, which primarily focuses on a drug’s safety. But Viking said that in the study, its medicine led to a roughly 3.3% placebo-adjusted average weight loss after four weeks and that it showed no safety issues.

In preview notes, analysts had said that investors would want to see between 3% and 4% placebo-adjusted weight loss. Shares of San Diego-based Viking were up more than 20% in pre-market trading Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Change Healthcare payments predicted restored March 15

WSS

What it’s like to watch children die of measles

In his State of the Union, Biden takes clear aim at 'Big Pharma'

CDC marks new Covid

What AstraZeneca

5 wounded, 2 critically, in Michigan shopping center shooting

House GOP plan to stem drug shortages differs from Democrats’

Wikipedia

focus

Wikipedia

BioMarin wins approval for gene therapy to treat hemophilia A

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Walensky prepares to leave CDC — and Congress — behind

Snowpack in the West is melting rapidly. Where will all that extra water go?

Cancer drug shortages should be causing more outrage

Trump team launching legal defense fund to help pay legal bills

Moonlake's readout produced a cash windfall. Risks remain

Just how do doctors, lawmakers, and the public define abortion?

Virginia high school admissions case could be legal follow

American TikTok star stuck in Dubai for months following rental car altercation

explore

Trump team launching legal defense fund to help pay legal bills

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Campaign finance charge dropped from case against Sam Bankman

UnitedHealth quietly bought dozens of outpatient centers

RSV shot was 90% effective at preventing hospitalizations in kids

IVF, abortion rights issues kick off Biden’s State of the Union

hotspot

focus

hotspot

focus